Even with a low cutoff value (10-20 ng/mL), its specificity remains inadequate, resulting in many HCC patients being missed (30%-40%).12 In the case of AFP-negative HCC (ANHC), characterized by smaller tumor masses, imaging examinations are also prone to missing the diagnosis.13 This evidence concerns the gene AFP and neoplasm.